Originally published on BMS.com in recognition of Health Literacy Month, the following article highlights how Bristol Myers Squibb's Universal Patient…
Prestigious European Society for Medical Oncology Conference “trials-in-progress” session Pivotal OVATION 3 trial of its DNA-mediated immunotherapy in newly diagnosed…
Expanded agreement strengthens Zomedica's European presence, broadens product portfolio on the market, and positions the Company to capture growth in…
$50 million drawn down at closing, with access to up to an additional $80 millionStrengthens Company’s financial position; enables initiation…
NEEDHAM, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical…
Acquisition Expands R1’s Agentic AI Capabilities to Help Providers Unlock Clinical and Financial ValueMURRAY, Utah, Oct. 14, 2025 (GLOBE NEWSWIRE)…
The Foresight® Carrier Screen includes all conditions recommended by the American College of Medical Genetics and Genomics recommendationsSALT LAKE CITY,…
Appoints Shawn Matthews, CEO of DNA Holdings Venture, Inc., and Former CEO of Cantor Fitzgerald, to its Board of Directors…
FDA agrees with Phase 2b/3 clinical design, including primary endpoint and development approach, providing clear regulatory pathway to conduct two…
New Offerings Bring Millions Affordable Healthcare Solutions During Open Enrollment SeasonDRAPER, Utah, Oct. 14, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc.…